nodes	percent_of_prediction	percent_of_DWPC	metapath
Nelarabine—Nucleic Acid Synthesis Inhibitors—Gemcitabine—lung cancer	0.463	1	CiPCiCtD
Nelarabine—DCK—Pemetrexed—lung cancer	0.124	0.514	CbGbCtD
Nelarabine—POLA1—Gemcitabine—lung cancer	0.0723	0.301	CbGbCtD
Nelarabine—Cytarabine—Gemcitabine—lung cancer	0.0592	0.35	CrCrCtD
Nelarabine—Azacitidine—Gemcitabine—lung cancer	0.0562	0.333	CrCrCtD
Nelarabine—Decitabine—Gemcitabine—lung cancer	0.0535	0.317	CrCrCtD
Nelarabine—DCK—Gemcitabine—lung cancer	0.0445	0.185	CbGbCtD
Nelarabine—ADA—pleura—lung cancer	0.00953	0.367	CbGeAlD
Nelarabine—DGUOK—mammary gland—lung cancer	0.00248	0.0957	CbGeAlD
Nelarabine—POLA1—mammary gland—lung cancer	0.00153	0.0591	CbGeAlD
Nelarabine—DGUOK—bronchus—lung cancer	0.00136	0.0525	CbGeAlD
Nelarabine—DGUOK—trachea—lung cancer	0.00122	0.0471	CbGeAlD
Nelarabine—DGUOK—cardiac atrium—lung cancer	0.00115	0.0443	CbGeAlD
Nelarabine—DGUOK—bone marrow—lung cancer	0.00097	0.0374	CbGeAlD
Nelarabine—ADA—respiratory system—lung cancer	0.000947	0.0365	CbGeAlD
Nelarabine—DGUOK—lung—lung cancer	0.000879	0.0339	CbGeAlD
Nelarabine—DGUOK—lymph node—lung cancer	0.000601	0.0232	CbGeAlD
Nelarabine—POLA1—bone marrow—lung cancer	0.000598	0.0231	CbGeAlD
Nelarabine—DCK—Topotecan—Irinotecan—lung cancer	0.000558	0.463	CbGdCrCtD
Nelarabine—ADA—bone marrow—lung cancer	0.000555	0.0214	CbGeAlD
Nelarabine—POLA1—lung—lung cancer	0.000542	0.0209	CbGeAlD
Nelarabine—POLA1—Vinblastine—Vinorelbine—lung cancer	0.000525	0.436	CbGdCrCtD
Nelarabine—DCK—bronchus—lung cancer	0.000518	0.02	CbGeAlD
Nelarabine—ADA—lung—lung cancer	0.000503	0.0194	CbGeAlD
Nelarabine—DCK—trachea—lung cancer	0.000465	0.0179	CbGeAlD
Nelarabine—DCK—cardiac atrium—lung cancer	0.000437	0.0168	CbGeAlD
Nelarabine—Adenosine monophosphate—ADCY1—lung cancer	0.000375	0.165	CrCbGaD
Nelarabine—POLA1—lymph node—lung cancer	0.000371	0.0143	CbGeAlD
Nelarabine—DCK—bone marrow—lung cancer	0.000369	0.0142	CbGeAlD
Nelarabine—ADA—lymph node—lung cancer	0.000344	0.0133	CbGeAlD
Nelarabine—Abacavir—UGT1A1—lung cancer	0.000339	0.15	CrCbGaD
Nelarabine—DCK—lung—lung cancer	0.000334	0.0129	CbGeAlD
Nelarabine—Adenosine triphosphate—ADCY1—lung cancer	0.000325	0.143	CrCbGaD
Nelarabine—Clofarabine—RRM1—lung cancer	0.000298	0.131	CrCbGaD
Nelarabine—Fludarabine—RRM1—lung cancer	0.000288	0.127	CrCbGaD
Nelarabine—DCK—lymph node—lung cancer	0.000229	0.00881	CbGeAlD
Nelarabine—Cladribine—RRM1—lung cancer	0.000171	0.0754	CrCbGaD
Nelarabine—DCK—Epirubicin—Doxorubicin—lung cancer	0.000121	0.101	CbGdCrCtD
Nelarabine—Adenosine triphosphate—ALK—lung cancer	0.000113	0.0499	CrCbGaD
Nelarabine—Adenosine triphosphate—AKT1—lung cancer	8.84e-05	0.039	CrCbGaD
Nelarabine—Adenosine monophosphate—SRC—lung cancer	8.71e-05	0.0384	CrCbGaD
Nelarabine—Clofarabine—ABCG2—lung cancer	7.59e-05	0.0335	CrCbGaD
Nelarabine—ADA—C-MYB transcription factor network—CDKN1A—lung cancer	6.34e-05	0.00223	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—NCOA3—lung cancer	6.34e-05	0.00223	CbGpPWpGaD
Nelarabine—ADA—p73 transcription factor network—EP300—lung cancer	6.34e-05	0.00223	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—ABCG2—lung cancer	6.17e-05	0.00217	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—ADCY1—lung cancer	6.17e-05	0.00217	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—APP—lung cancer	6.16e-05	0.00216	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—HPGDS—lung cancer	6.05e-05	0.00213	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—ENO2—lung cancer	6.05e-05	0.00213	CbGpPWpGaD
Nelarabine—ADA—Metabolism—COL4A3BP—lung cancer	6.05e-05	0.00213	CbGpPWpGaD
Nelarabine—ADA—Metabolism—AZIN2—lung cancer	6.05e-05	0.00213	CbGpPWpGaD
Nelarabine—ADA—C-MYB transcription factor network—EP300—lung cancer	6.04e-05	0.00212	CbGpPWpGaD
Nelarabine—POLA1—Mitotic G1-G1/S phases—TYMS—lung cancer	6.02e-05	0.00211	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—PPP2R1B—lung cancer	6.01e-05	0.00211	CbGpPWpGaD
Nelarabine—DCK—Retinoblastoma (RB) in Cancer—CCND1—lung cancer	5.88e-05	0.00207	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—GSTT1—lung cancer	5.87e-05	0.00206	CbGpPWpGaD
Nelarabine—POLA1—E2F transcription factor network—CDKN2A—lung cancer	5.87e-05	0.00206	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—JUNB—lung cancer	5.84e-05	0.00205	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—CYP2A6—lung cancer	5.8e-05	0.00204	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—GCLC—lung cancer	5.8e-05	0.00204	CbGpPWpGaD
Nelarabine—POLA1—Retinoblastoma (RB) in Cancer—RB1—lung cancer	5.8e-05	0.00204	CbGpPWpGaD
Nelarabine—DCK—Retinoblastoma (RB) in Cancer—CDKN1A—lung cancer	5.69e-05	0.002	CbGpPWpGaD
Nelarabine—ADA—C-MYB transcription factor network—NRAS—lung cancer	5.65e-05	0.00198	CbGpPWpGaD
Nelarabine—DCK—Metabolism—AZIN2—lung cancer	5.58e-05	0.00196	CbGpPWpGaD
Nelarabine—DCK—Metabolism—COL4A3BP—lung cancer	5.58e-05	0.00196	CbGpPWpGaD
Nelarabine—ADA—p73 transcription factor network—MYC—lung cancer	5.53e-05	0.00194	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—ENO1—lung cancer	5.5e-05	0.00193	CbGpPWpGaD
Nelarabine—POLA1—Synthesis of DNA—RB1—lung cancer	5.36e-05	0.00188	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—STK11—lung cancer	5.3e-05	0.00186	CbGpPWpGaD
Nelarabine—ADA—C-MYB transcription factor network—MYC—lung cancer	5.26e-05	0.00185	CbGpPWpGaD
Nelarabine—ADA—Metabolism—ATP5H—lung cancer	5.15e-05	0.00181	CbGpPWpGaD
Nelarabine—POLA1—DNA Replication—RB1—lung cancer	5.03e-05	0.00177	CbGpPWpGaD
Nelarabine—POLA1—Retinoblastoma (RB) in Cancer—MDM2—lung cancer	4.94e-05	0.00174	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—CYP2E1—lung cancer	4.93e-05	0.00173	CbGpPWpGaD
Nelarabine—POLA1—Retinoblastoma (RB) in Cancer—RAF1—lung cancer	4.93e-05	0.00173	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—NQO1—lung cancer	4.88e-05	0.00171	CbGpPWpGaD
Nelarabine—ADA—C-MYB transcription factor network—KRAS—lung cancer	4.86e-05	0.00171	CbGpPWpGaD
Nelarabine—POLA1—G1/S Transition—RB1—lung cancer	4.84e-05	0.0017	CbGpPWpGaD
Nelarabine—POLA1—E2F transcription factor network—CDKN1A—lung cancer	4.79e-05	0.00168	CbGpPWpGaD
Nelarabine—S-Adenosylmethionine—CYP2E1—lung cancer	4.76e-05	0.021	CrCbGaD
Nelarabine—DCK—Metabolism—ATP5H—lung cancer	4.75e-05	0.00167	CbGpPWpGaD
Nelarabine—DCK—Retinoblastoma (RB) in Cancer—MYC—lung cancer	4.72e-05	0.00166	CbGpPWpGaD
Nelarabine—POLA1—Mitotic M-M/G1 phases—PPP2R1B—lung cancer	4.69e-05	0.00165	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—ABCB1—lung cancer	4.64e-05	0.00163	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PLBD1—lung cancer	4.59e-05	0.00161	CbGpPWpGaD
Nelarabine—POLA1—E2F transcription factor network—EP300—lung cancer	4.56e-05	0.0016	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—TYMS—lung cancer	4.56e-05	0.0016	CbGpPWpGaD
Nelarabine—POLA1—Mitotic M-M/G1 phases—LMNA—lung cancer	4.48e-05	0.00157	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—STK11—lung cancer	4.4e-05	0.00154	CbGpPWpGaD
Nelarabine—POLA1—S Phase—RB1—lung cancer	4.4e-05	0.00154	CbGpPWpGaD
Nelarabine—Cladribine—ABCG2—lung cancer	4.36e-05	0.0192	CrCbGaD
Nelarabine—POLA1—Retinoblastoma (RB) in Cancer—CCND1—lung cancer	4.31e-05	0.00151	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—FOXM1—lung cancer	4.24e-05	0.00149	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PLBD1—lung cancer	4.23e-05	0.00149	CbGpPWpGaD
Nelarabine—ADA—Metabolism—HSD17B10—lung cancer	4.19e-05	0.00147	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—FASLG—lung cancer	4.19e-05	0.00147	CbGpPWpGaD
Nelarabine—POLA1—Retinoblastoma (RB) in Cancer—CDKN1A—lung cancer	4.17e-05	0.00146	CbGpPWpGaD
Nelarabine—ADA—C-MYB transcription factor network—HRAS—lung cancer	4.13e-05	0.00145	CbGpPWpGaD
Nelarabine—POLA1—Mitotic G1-G1/S phases—RB1—lung cancer	4.08e-05	0.00143	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—GSTP1—lung cancer	4.07e-05	0.00143	CbGpPWpGaD
Nelarabine—POLA1—E2F transcription factor network—MYC—lung cancer	3.98e-05	0.0014	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—CAT—lung cancer	3.96e-05	0.00139	CbGpPWpGaD
Nelarabine—ADA—Metabolism—CKB—lung cancer	3.9e-05	0.00137	CbGpPWpGaD
Nelarabine—DCK—Retinoblastoma (RB) in Cancer—TP53—lung cancer	3.88e-05	0.00136	CbGpPWpGaD
Nelarabine—DCK—Metabolism—HSD17B10—lung cancer	3.87e-05	0.00136	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—FGFR1—lung cancer	3.86e-05	0.00135	CbGpPWpGaD
Nelarabine—POLA1—Synthesis of DNA—CDKN1A—lung cancer	3.85e-05	0.00135	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—ABCB1—lung cancer	3.85e-05	0.00135	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—FOXM1—lung cancer	3.79e-05	0.00133	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—TYMS—lung cancer	3.78e-05	0.00133	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—GSTM1—lung cancer	3.74e-05	0.00131	CbGpPWpGaD
Nelarabine—ADA—Metabolism—GSTM2—lung cancer	3.67e-05	0.00129	CbGpPWpGaD
Nelarabine—ADA—Metabolism—CNDP2—lung cancer	3.67e-05	0.00129	CbGpPWpGaD
Nelarabine—POLA1—DNA Replication—CDKN1A—lung cancer	3.61e-05	0.00127	CbGpPWpGaD
Nelarabine—DCK—Metabolism—CKB—lung cancer	3.6e-05	0.00126	CbGpPWpGaD
Nelarabine—POLA1—Mitotic G1-G1/S phases—CDKN2A—lung cancer	3.59e-05	0.00126	CbGpPWpGaD
Nelarabine—ADA—Metabolism—MTMR3—lung cancer	3.57e-05	0.00125	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—CYP1A1—lung cancer	3.54e-05	0.00124	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—ERCC2—lung cancer	3.51e-05	0.00123	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—PPP2R1B—lung cancer	3.51e-05	0.00123	CbGpPWpGaD
Nelarabine—POLA1—G1/S Transition—CDKN1A—lung cancer	3.48e-05	0.00122	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PGAM1—lung cancer	3.48e-05	0.00122	CbGpPWpGaD
Nelarabine—POLA1—Retinoblastoma (RB) in Cancer—MYC—lung cancer	3.45e-05	0.00121	CbGpPWpGaD
Nelarabine—DCK—Metabolism—CNDP2—lung cancer	3.38e-05	0.00119	CbGpPWpGaD
Nelarabine—DCK—Metabolism—GSTM2—lung cancer	3.38e-05	0.00119	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—LMNA—lung cancer	3.35e-05	0.00118	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—APC—lung cancer	3.35e-05	0.00118	CbGpPWpGaD
Nelarabine—ADA—Metabolism—CYP2A7—lung cancer	3.32e-05	0.00116	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—EGF—lung cancer	3.31e-05	0.00116	CbGpPWpGaD
Nelarabine—DCK—Metabolism—MTMR3—lung cancer	3.29e-05	0.00116	CbGpPWpGaD
Nelarabine—POLA1—S Phase—CCND1—lung cancer	3.27e-05	0.00115	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—JUN—lung cancer	3.26e-05	0.00114	CbGpPWpGaD
Nelarabine—ADA—Metabolism—SDC4—lung cancer	3.24e-05	0.00114	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PGAM1—lung cancer	3.21e-05	0.00113	CbGpPWpGaD
Nelarabine—POLA1—S Phase—CDKN1A—lung cancer	3.16e-05	0.00111	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—PTEN—lung cancer	3.15e-05	0.00111	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—PPP2R1B—lung cancer	3.14e-05	0.0011	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—CASP8—lung cancer	3.12e-05	0.00109	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—CREBBP—lung cancer	3.1e-05	0.00109	CbGpPWpGaD
Nelarabine—DCK—Metabolism—CYP2A7—lung cancer	3.06e-05	0.00107	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—APOA1—lung cancer	3.04e-05	0.00107	CbGpPWpGaD
Nelarabine—POLA1—Mitotic G1-G1/S phases—CCND1—lung cancer	3.03e-05	0.00106	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—EP300—lung cancer	3e-05	0.00105	CbGpPWpGaD
Nelarabine—DCK—Metabolism—SDC4—lung cancer	2.99e-05	0.00105	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—LMNA—lung cancer	2.99e-05	0.00105	CbGpPWpGaD
Nelarabine—Myalgia—Paclitaxel—lung cancer	2.98e-05	0.000425	CcSEcCtD
Nelarabine—Hypotension—Cisplatin—lung cancer	2.97e-05	0.000423	CcSEcCtD
Nelarabine—Malnutrition—Docetaxel—lung cancer	2.96e-05	0.000423	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—MAP2K1—lung cancer	2.96e-05	0.00104	CbGpPWpGaD
Nelarabine—Decreased appetite—Gemcitabine—lung cancer	2.96e-05	0.000423	CcSEcCtD
Nelarabine—ADA—Metabolism—RRM1—lung cancer	2.96e-05	0.00104	CbGpPWpGaD
Nelarabine—ADA—Metabolism—GSTA3—lung cancer	2.96e-05	0.00104	CbGpPWpGaD
Nelarabine—Nausea—Topotecan—lung cancer	2.94e-05	0.00042	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Gemcitabine—lung cancer	2.94e-05	0.00042	CcSEcCtD
Nelarabine—Fatigue—Gemcitabine—lung cancer	2.94e-05	0.000419	CcSEcCtD
Nelarabine—Confusional state—Etoposide—lung cancer	2.93e-05	0.000419	CcSEcCtD
Nelarabine—POLA1—Mitotic G1-G1/S phases—CDKN1A—lung cancer	2.93e-05	0.00103	CbGpPWpGaD
Nelarabine—Constipation—Gemcitabine—lung cancer	2.91e-05	0.000416	CcSEcCtD
Nelarabine—Pain—Gemcitabine—lung cancer	2.91e-05	0.000416	CcSEcCtD
Nelarabine—Nausea—Erlotinib—lung cancer	2.91e-05	0.000416	CcSEcCtD
Nelarabine—Diarrhoea—Vinorelbine—lung cancer	2.9e-05	0.000414	CcSEcCtD
Nelarabine—Dysgeusia—Docetaxel—lung cancer	2.9e-05	0.000414	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Cisplatin—lung cancer	2.89e-05	0.000413	CcSEcCtD
Nelarabine—Infection—Etoposide—lung cancer	2.89e-05	0.000412	CcSEcCtD
Nelarabine—Ataxia—Doxorubicin—lung cancer	2.89e-05	0.000412	CcSEcCtD
Nelarabine—POLA1—G1/S Transition—MYC—lung cancer	2.88e-05	0.00101	CbGpPWpGaD
Nelarabine—Feeling abnormal—Irinotecan—lung cancer	2.88e-05	0.000411	CcSEcCtD
Nelarabine—Confusional state—Paclitaxel—lung cancer	2.88e-05	0.00041	CcSEcCtD
Nelarabine—Blood creatinine increased—Doxorubicin—lung cancer	2.88e-05	0.00041	CcSEcCtD
Nelarabine—Back pain—Docetaxel—lung cancer	2.87e-05	0.000409	CcSEcCtD
Nelarabine—Neutropenia—Methotrexate—lung cancer	2.87e-05	0.000409	CcSEcCtD
Nelarabine—Gastrointestinal pain—Irinotecan—lung cancer	2.86e-05	0.000408	CcSEcCtD
Nelarabine—Dehydration—Doxorubicin—lung cancer	2.85e-05	0.000407	CcSEcCtD
Nelarabine—Oedema—Paclitaxel—lung cancer	2.85e-05	0.000407	CcSEcCtD
Nelarabine—Paraesthesia—Cisplatin—lung cancer	2.85e-05	0.000407	CcSEcCtD
Nelarabine—Thrombocytopenia—Etoposide—lung cancer	2.85e-05	0.000406	CcSEcCtD
Nelarabine—POLA1—Retinoblastoma (RB) in Cancer—TP53—lung cancer	2.84e-05	0.000996	CbGpPWpGaD
Nelarabine—Infection—Paclitaxel—lung cancer	2.83e-05	0.000404	CcSEcCtD
Nelarabine—Dyspnoea—Cisplatin—lung cancer	2.83e-05	0.000404	CcSEcCtD
Nelarabine—Feeling abnormal—Gemcitabine—lung cancer	2.81e-05	0.000401	CcSEcCtD
Nelarabine—Dizziness—Vinorelbine—lung cancer	2.8e-05	0.0004	CcSEcCtD
Nelarabine—Nervous system disorder—Paclitaxel—lung cancer	2.8e-05	0.000399	CcSEcCtD
Nelarabine—Hypokalaemia—Doxorubicin—lung cancer	2.79e-05	0.000399	CcSEcCtD
Nelarabine—Thrombocytopenia—Paclitaxel—lung cancer	2.79e-05	0.000399	CcSEcCtD
Nelarabine—ADA—Metabolism—B4GALT5—lung cancer	2.78e-05	0.000976	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—PIK3CG—lung cancer	2.78e-05	0.000975	CbGpPWpGaD
Nelarabine—Anorexia—Etoposide—lung cancer	2.77e-05	0.000396	CcSEcCtD
Nelarabine—Abdominal pain—Irinotecan—lung cancer	2.76e-05	0.000395	CcSEcCtD
Nelarabine—Body temperature increased—Irinotecan—lung cancer	2.76e-05	0.000395	CcSEcCtD
Nelarabine—Aspartate aminotransferase increased—Doxorubicin—lung cancer	2.76e-05	0.000395	CcSEcCtD
Nelarabine—Decreased appetite—Cisplatin—lung cancer	2.76e-05	0.000394	CcSEcCtD
Nelarabine—Pneumonia—Methotrexate—lung cancer	2.75e-05	0.000392	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Cisplatin—lung cancer	2.74e-05	0.000391	CcSEcCtD
Nelarabine—Anaemia—Docetaxel—lung cancer	2.74e-05	0.000391	CcSEcCtD
Nelarabine—Infestation—Methotrexate—lung cancer	2.73e-05	0.00039	CcSEcCtD
Nelarabine—Infestation NOS—Methotrexate—lung cancer	2.73e-05	0.00039	CcSEcCtD
Nelarabine—DCK—Metabolism—RRM1—lung cancer	2.73e-05	0.000958	CbGpPWpGaD
Nelarabine—DCK—Metabolism—GSTA3—lung cancer	2.73e-05	0.000958	CbGpPWpGaD
Nelarabine—Depression—Methotrexate—lung cancer	2.72e-05	0.000389	CcSEcCtD
Nelarabine—Anorexia—Paclitaxel—lung cancer	2.72e-05	0.000388	CcSEcCtD
Nelarabine—Hypotension—Etoposide—lung cancer	2.72e-05	0.000388	CcSEcCtD
Nelarabine—Pain—Cisplatin—lung cancer	2.72e-05	0.000388	CcSEcCtD
Nelarabine—Muscular weakness—Doxorubicin—lung cancer	2.71e-05	0.000386	CcSEcCtD
Nelarabine—ADA—Metabolism—GSTA4—lung cancer	2.7e-05	0.000949	CbGpPWpGaD
Nelarabine—Vomiting—Vinorelbine—lung cancer	2.7e-05	0.000385	CcSEcCtD
Nelarabine—Body temperature increased—Gemcitabine—lung cancer	2.69e-05	0.000384	CcSEcCtD
Nelarabine—Abdominal distension—Doxorubicin—lung cancer	2.67e-05	0.000381	CcSEcCtD
Nelarabine—Hypotension—Paclitaxel—lung cancer	2.67e-05	0.00038	CcSEcCtD
Nelarabine—Stomatitis—Methotrexate—lung cancer	2.66e-05	0.00038	CcSEcCtD
Nelarabine—Headache—Vinorelbine—lung cancer	2.66e-05	0.000379	CcSEcCtD
Nelarabine—POLA1—Mitotic M-M/G1 phases—BIRC5—lung cancer	2.65e-05	0.000932	CbGpPWpGaD
Nelarabine—Leukopenia—Docetaxel—lung cancer	2.65e-05	0.000378	CcSEcCtD
Nelarabine—DGUOK—Metabolism—POMC—lung cancer	2.64e-05	0.000928	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—MDM2—lung cancer	2.64e-05	0.000926	CbGpPWpGaD
Nelarabine—ADA—Metabolism—GSTA2—lung cancer	2.63e-05	0.000925	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—RAF1—lung cancer	2.63e-05	0.000923	CbGpPWpGaD
Nelarabine—POLA1—S Phase—MYC—lung cancer	2.62e-05	0.00092	CbGpPWpGaD
Nelarabine—Feeling abnormal—Cisplatin—lung cancer	2.62e-05	0.000373	CcSEcCtD
Nelarabine—Paraesthesia—Etoposide—lung cancer	2.61e-05	0.000373	CcSEcCtD
Nelarabine—Loss of consciousness—Docetaxel—lung cancer	2.6e-05	0.000372	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—ERBB2—lung cancer	2.6e-05	0.000913	CbGpPWpGaD
Nelarabine—Musculoskeletal discomfort—Paclitaxel—lung cancer	2.6e-05	0.000371	CcSEcCtD
Nelarabine—Dyspnoea—Etoposide—lung cancer	2.59e-05	0.00037	CcSEcCtD
Nelarabine—Somnolence—Etoposide—lung cancer	2.59e-05	0.000369	CcSEcCtD
Nelarabine—Cough—Docetaxel—lung cancer	2.58e-05	0.000369	CcSEcCtD
Nelarabine—Hepatobiliary disease—Methotrexate—lung cancer	2.58e-05	0.000369	CcSEcCtD
Nelarabine—Insomnia—Paclitaxel—lung cancer	2.58e-05	0.000368	CcSEcCtD
Nelarabine—Epistaxis—Methotrexate—lung cancer	2.58e-05	0.000368	CcSEcCtD
Nelarabine—DGUOK—Metabolism—CREBBP—lung cancer	2.57e-05	0.000904	CbGpPWpGaD
Nelarabine—Convulsion—Docetaxel—lung cancer	2.57e-05	0.000366	CcSEcCtD
Nelarabine—DCK—Metabolism—B4GALT5—lung cancer	2.56e-05	0.0009	CbGpPWpGaD
Nelarabine—Paraesthesia—Paclitaxel—lung cancer	2.56e-05	0.000366	CcSEcCtD
Nelarabine—Dyspnoea—Paclitaxel—lung cancer	2.54e-05	0.000363	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—PTGS2—lung cancer	2.54e-05	0.000892	CbGpPWpGaD
Nelarabine—ADA—Metabolism—GSTA1—lung cancer	2.54e-05	0.000892	CbGpPWpGaD
Nelarabine—Somnolence—Paclitaxel—lung cancer	2.54e-05	0.000362	CcSEcCtD
Nelarabine—Decreased appetite—Etoposide—lung cancer	2.53e-05	0.000361	CcSEcCtD
Nelarabine—Chest pain—Docetaxel—lung cancer	2.52e-05	0.00036	CcSEcCtD
Nelarabine—Myalgia—Docetaxel—lung cancer	2.52e-05	0.00036	CcSEcCtD
Nelarabine—Arthralgia—Docetaxel—lung cancer	2.52e-05	0.00036	CcSEcCtD
Nelarabine—Nausea—Vinorelbine—lung cancer	2.52e-05	0.000359	CcSEcCtD
Nelarabine—ADA—Metabolism—ABCC3—lung cancer	2.51e-05	0.000882	CbGpPWpGaD
Nelarabine—Gastrointestinal disorder—Etoposide—lung cancer	2.51e-05	0.000358	CcSEcCtD
Nelarabine—Body temperature increased—Cisplatin—lung cancer	2.51e-05	0.000358	CcSEcCtD
Nelarabine—Asthenia—Irinotecan—lung cancer	2.51e-05	0.000358	CcSEcCtD
Nelarabine—Fatigue—Etoposide—lung cancer	2.51e-05	0.000358	CcSEcCtD
Nelarabine—DCK—Metabolism—GSTA4—lung cancer	2.49e-05	0.000876	CbGpPWpGaD
Nelarabine—Constipation—Etoposide—lung cancer	2.49e-05	0.000355	CcSEcCtD
Nelarabine—Pain—Etoposide—lung cancer	2.49e-05	0.000355	CcSEcCtD
Nelarabine—Neutropenia—Doxorubicin—lung cancer	2.48e-05	0.000354	CcSEcCtD
Nelarabine—Decreased appetite—Paclitaxel—lung cancer	2.48e-05	0.000354	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Paclitaxel—lung cancer	2.46e-05	0.000351	CcSEcCtD
Nelarabine—Fatigue—Paclitaxel—lung cancer	2.46e-05	0.000351	CcSEcCtD
Nelarabine—Asthenia—Gemcitabine—lung cancer	2.44e-05	0.000349	CcSEcCtD
Nelarabine—DGUOK—Metabolism—PIK3CD—lung cancer	2.44e-05	0.000857	CbGpPWpGaD
Nelarabine—Pain—Paclitaxel—lung cancer	2.44e-05	0.000348	CcSEcCtD
Nelarabine—Constipation—Paclitaxel—lung cancer	2.44e-05	0.000348	CcSEcCtD
Nelarabine—Confusional state—Docetaxel—lung cancer	2.44e-05	0.000348	CcSEcCtD
Nelarabine—ADA—Metabolism—AKR1C1—lung cancer	2.43e-05	0.000855	CbGpPWpGaD
Nelarabine—POLA1—Mitotic G1-G1/S phases—MYC—lung cancer	2.43e-05	0.000854	CbGpPWpGaD
Nelarabine—DCK—Metabolism—GSTA2—lung cancer	2.43e-05	0.000854	CbGpPWpGaD
Nelarabine—Urinary tract disorder—Methotrexate—lung cancer	2.42e-05	0.000346	CcSEcCtD
Nelarabine—Oedema—Docetaxel—lung cancer	2.42e-05	0.000345	CcSEcCtD
Nelarabine—DGUOK—Metabolism—ALB—lung cancer	2.41e-05	0.000846	CbGpPWpGaD
Nelarabine—Urethral disorder—Methotrexate—lung cancer	2.4e-05	0.000343	CcSEcCtD
Nelarabine—Infection—Docetaxel—lung cancer	2.4e-05	0.000343	CcSEcCtD
Nelarabine—Feeling abnormal—Etoposide—lung cancer	2.4e-05	0.000342	CcSEcCtD
Nelarabine—Hyperglycaemia—Doxorubicin—lung cancer	2.39e-05	0.000342	CcSEcCtD
Nelarabine—Diarrhoea—Irinotecan—lung cancer	2.39e-05	0.000342	CcSEcCtD
Nelarabine—Pneumonia—Doxorubicin—lung cancer	2.38e-05	0.00034	CcSEcCtD
Nelarabine—Gastrointestinal pain—Etoposide—lung cancer	2.38e-05	0.000339	CcSEcCtD
Nelarabine—Nervous system disorder—Docetaxel—lung cancer	2.37e-05	0.000338	CcSEcCtD
Nelarabine—Thrombocytopenia—Docetaxel—lung cancer	2.37e-05	0.000338	CcSEcCtD
Nelarabine—Infestation NOS—Doxorubicin—lung cancer	2.37e-05	0.000338	CcSEcCtD
Nelarabine—Infestation—Doxorubicin—lung cancer	2.37e-05	0.000338	CcSEcCtD
Nelarabine—ADA—Metabolism—UGT1A1—lung cancer	2.36e-05	0.00083	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—CASP3—lung cancer	2.36e-05	0.000828	CbGpPWpGaD
Nelarabine—Feeling abnormal—Paclitaxel—lung cancer	2.35e-05	0.000335	CcSEcCtD
Nelarabine—DCK—Metabolism—GSTA1—lung cancer	2.35e-05	0.000824	CbGpPWpGaD
Nelarabine—Gastrointestinal pain—Paclitaxel—lung cancer	2.33e-05	0.000333	CcSEcCtD
Nelarabine—Diarrhoea—Gemcitabine—lung cancer	2.33e-05	0.000333	CcSEcCtD
Nelarabine—DCK—Metabolism—ABCC3—lung cancer	2.32e-05	0.000814	CbGpPWpGaD
Nelarabine—Neuropathy peripheral—Doxorubicin—lung cancer	2.32e-05	0.000331	CcSEcCtD
Nelarabine—Dizziness—Irinotecan—lung cancer	2.31e-05	0.00033	CcSEcCtD
Nelarabine—Stomatitis—Doxorubicin—lung cancer	2.31e-05	0.000329	CcSEcCtD
Nelarabine—Anorexia—Docetaxel—lung cancer	2.3e-05	0.000329	CcSEcCtD
Nelarabine—Abdominal pain—Etoposide—lung cancer	2.3e-05	0.000328	CcSEcCtD
Nelarabine—Body temperature increased—Etoposide—lung cancer	2.3e-05	0.000328	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—CCND1—lung cancer	2.3e-05	0.000806	CbGpPWpGaD
Nelarabine—Eye disorder—Methotrexate—lung cancer	2.29e-05	0.000327	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—JUN—lung cancer	2.29e-05	0.000805	CbGpPWpGaD
Nelarabine—Asthenia—Cisplatin—lung cancer	2.28e-05	0.000325	CcSEcCtD
Nelarabine—ADA—Metabolism—GNG11—lung cancer	2.28e-05	0.0008	CbGpPWpGaD
Nelarabine—Cardiac disorder—Methotrexate—lung cancer	2.28e-05	0.000325	CcSEcCtD
Nelarabine—Hypotension—Docetaxel—lung cancer	2.26e-05	0.000322	CcSEcCtD
Nelarabine—Abdominal pain—Paclitaxel—lung cancer	2.25e-05	0.000322	CcSEcCtD
Nelarabine—Body temperature increased—Paclitaxel—lung cancer	2.25e-05	0.000322	CcSEcCtD
Nelarabine—DCK—Metabolism—AKR1C1—lung cancer	2.25e-05	0.000789	CbGpPWpGaD
Nelarabine—Hepatobiliary disease—Doxorubicin—lung cancer	2.24e-05	0.000319	CcSEcCtD
Nelarabine—Epistaxis—Doxorubicin—lung cancer	2.23e-05	0.000318	CcSEcCtD
Nelarabine—Angiopathy—Methotrexate—lung cancer	2.23e-05	0.000318	CcSEcCtD
Nelarabine—Vomiting—Irinotecan—lung cancer	2.22e-05	0.000317	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—CDKN1A—lung cancer	2.22e-05	0.00078	CbGpPWpGaD
Nelarabine—Sinusitis—Doxorubicin—lung cancer	2.22e-05	0.000317	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—PTEN—lung cancer	2.22e-05	0.000778	CbGpPWpGaD
Nelarabine—Mediastinal disorder—Methotrexate—lung cancer	2.21e-05	0.000315	CcSEcCtD
Nelarabine—POLA1—Cell Cycle, Mitotic—TYMS—lung cancer	2.21e-05	0.000775	CbGpPWpGaD
Nelarabine—Musculoskeletal discomfort—Docetaxel—lung cancer	2.2e-05	0.000314	CcSEcCtD
Nelarabine—Chills—Methotrexate—lung cancer	2.2e-05	0.000314	CcSEcCtD
Nelarabine—Headache—Irinotecan—lung cancer	2.19e-05	0.000313	CcSEcCtD
Nelarabine—Insomnia—Docetaxel—lung cancer	2.19e-05	0.000312	CcSEcCtD
Nelarabine—DCK—Metabolism—UGT1A1—lung cancer	2.18e-05	0.000766	CbGpPWpGaD
Nelarabine—Diarrhoea—Cisplatin—lung cancer	2.17e-05	0.00031	CcSEcCtD
Nelarabine—Paraesthesia—Docetaxel—lung cancer	2.17e-05	0.00031	CcSEcCtD
Nelarabine—ADA—Metabolism—ALDOA—lung cancer	2.17e-05	0.000762	CbGpPWpGaD
Nelarabine—Vomiting—Gemcitabine—lung cancer	2.17e-05	0.000309	CcSEcCtD
Nelarabine—Dyspnoea—Docetaxel—lung cancer	2.16e-05	0.000308	CcSEcCtD
Nelarabine—ADA—Circadian rythm related genes—TP53—lung cancer	2.15e-05	0.000755	CbGpPWpGaD
Nelarabine—Somnolence—Docetaxel—lung cancer	2.15e-05	0.000307	CcSEcCtD
Nelarabine—Mental disorder—Methotrexate—lung cancer	2.15e-05	0.000307	CcSEcCtD
Nelarabine—Malnutrition—Methotrexate—lung cancer	2.13e-05	0.000305	CcSEcCtD
Nelarabine—Headache—Gemcitabine—lung cancer	2.13e-05	0.000305	CcSEcCtD
Nelarabine—DGUOK—Metabolism—PIK3CB—lung cancer	2.13e-05	0.000747	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—EP300—lung cancer	2.11e-05	0.000742	CbGpPWpGaD
Nelarabine—Hypoaesthesia—Doxorubicin—lung cancer	2.11e-05	0.000302	CcSEcCtD
Nelarabine—DGUOK—Metabolism—PTGS2—lung cancer	2.11e-05	0.00074	CbGpPWpGaD
Nelarabine—ADA—Metabolism—NCOA3—lung cancer	2.11e-05	0.000739	CbGpPWpGaD
Nelarabine—DCK—Metabolism—GNG11—lung cancer	2.1e-05	0.000738	CbGpPWpGaD
Nelarabine—Decreased appetite—Docetaxel—lung cancer	2.1e-05	0.0003	CcSEcCtD
Nelarabine—Urinary tract disorder—Doxorubicin—lung cancer	2.1e-05	0.000299	CcSEcCtD
Nelarabine—Oedema peripheral—Doxorubicin—lung cancer	2.09e-05	0.000299	CcSEcCtD
Nelarabine—Dysgeusia—Methotrexate—lung cancer	2.09e-05	0.000298	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Docetaxel—lung cancer	2.09e-05	0.000298	CcSEcCtD
Nelarabine—Asthenia—Etoposide—lung cancer	2.09e-05	0.000298	CcSEcCtD
Nelarabine—Connective tissue disorder—Doxorubicin—lung cancer	2.09e-05	0.000298	CcSEcCtD
Nelarabine—Fatigue—Docetaxel—lung cancer	2.08e-05	0.000297	CcSEcCtD
Nelarabine—Urethral disorder—Doxorubicin—lung cancer	2.08e-05	0.000297	CcSEcCtD
Nelarabine—Nausea—Irinotecan—lung cancer	2.08e-05	0.000296	CcSEcCtD
Nelarabine—Constipation—Docetaxel—lung cancer	2.07e-05	0.000295	CcSEcCtD
Nelarabine—Pain—Docetaxel—lung cancer	2.07e-05	0.000295	CcSEcCtD
Nelarabine—Back pain—Methotrexate—lung cancer	2.07e-05	0.000295	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—SRC—lung cancer	2.06e-05	0.000722	CbGpPWpGaD
Nelarabine—ADA—Metabolism—ADCY1—lung cancer	2.05e-05	0.000719	CbGpPWpGaD
Nelarabine—ADA—Metabolism—ABCG2—lung cancer	2.05e-05	0.000719	CbGpPWpGaD
Nelarabine—Asthenia—Paclitaxel—lung cancer	2.05e-05	0.000292	CcSEcCtD
Nelarabine—Nausea—Gemcitabine—lung cancer	2.02e-05	0.000289	CcSEcCtD
Nelarabine—Vomiting—Cisplatin—lung cancer	2.02e-05	0.000288	CcSEcCtD
Nelarabine—Vision blurred—Methotrexate—lung cancer	2.01e-05	0.000287	CcSEcCtD
Nelarabine—ADA—Metabolism—HPGDS—lung cancer	2.01e-05	0.000705	CbGpPWpGaD
Nelarabine—ADA—Metabolism—ENO2—lung cancer	2.01e-05	0.000705	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—VEGFA—lung cancer	2e-05	0.000703	CbGpPWpGaD
Nelarabine—DCK—Metabolism—ALDOA—lung cancer	2e-05	0.000703	CbGpPWpGaD
Nelarabine—POLA1—Mitotic M-M/G1 phases—RB1—lung cancer	2e-05	0.000703	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PPP2R1B—lung cancer	2e-05	0.000701	CbGpPWpGaD
Nelarabine—Feeling abnormal—Docetaxel—lung cancer	1.99e-05	0.000284	CcSEcCtD
Nelarabine—Diarrhoea—Etoposide—lung cancer	1.99e-05	0.000284	CcSEcCtD
Nelarabine—POLA1—Cell Cycle, Mitotic—BIRC5—lung cancer	1.99e-05	0.000697	CbGpPWpGaD
Nelarabine—Eye disorder—Doxorubicin—lung cancer	1.98e-05	0.000283	CcSEcCtD
Nelarabine—Gastrointestinal pain—Docetaxel—lung cancer	1.98e-05	0.000282	CcSEcCtD
Nelarabine—POLA1—Cell Cycle—TYMS—lung cancer	1.97e-05	0.000693	CbGpPWpGaD
Nelarabine—Anaemia—Methotrexate—lung cancer	1.97e-05	0.000282	CcSEcCtD
Nelarabine—Cardiac disorder—Doxorubicin—lung cancer	1.97e-05	0.000281	CcSEcCtD
Nelarabine—ADA—Circadian rythm related genes—IL6—lung cancer	1.97e-05	0.000691	CbGpPWpGaD
Nelarabine—Diarrhoea—Paclitaxel—lung cancer	1.95e-05	0.000279	CcSEcCtD
Nelarabine—ADA—Metabolism—GSTT1—lung cancer	1.95e-05	0.000684	CbGpPWpGaD
Nelarabine—DCK—Metabolism—NCOA3—lung cancer	1.94e-05	0.000682	CbGpPWpGaD
Nelarabine—Angiopathy—Doxorubicin—lung cancer	1.93e-05	0.000275	CcSEcCtD
Nelarabine—ADA—Metabolism—GCLC—lung cancer	1.93e-05	0.000676	CbGpPWpGaD
Nelarabine—ADA—Metabolism—CYP2A6—lung cancer	1.93e-05	0.000676	CbGpPWpGaD
Nelarabine—Dizziness—Etoposide—lung cancer	1.92e-05	0.000275	CcSEcCtD
Nelarabine—Mediastinal disorder—Doxorubicin—lung cancer	1.91e-05	0.000273	CcSEcCtD
Nelarabine—Body temperature increased—Docetaxel—lung cancer	1.91e-05	0.000273	CcSEcCtD
Nelarabine—Abdominal pain—Docetaxel—lung cancer	1.91e-05	0.000273	CcSEcCtD
Nelarabine—Leukopenia—Methotrexate—lung cancer	1.91e-05	0.000273	CcSEcCtD
Nelarabine—Chills—Doxorubicin—lung cancer	1.91e-05	0.000272	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—MAPK3—lung cancer	1.89e-05	0.000665	CbGpPWpGaD
Nelarabine—DCK—Metabolism—ADCY1—lung cancer	1.89e-05	0.000664	CbGpPWpGaD
Nelarabine—DCK—Metabolism—ABCG2—lung cancer	1.89e-05	0.000664	CbGpPWpGaD
Nelarabine—Dizziness—Paclitaxel—lung cancer	1.89e-05	0.000269	CcSEcCtD
Nelarabine—Nausea—Cisplatin—lung cancer	1.89e-05	0.000269	CcSEcCtD
Nelarabine—Cough—Methotrexate—lung cancer	1.86e-05	0.000266	CcSEcCtD
Nelarabine—Mental disorder—Doxorubicin—lung cancer	1.86e-05	0.000266	CcSEcCtD
Nelarabine—DCK—Metabolism—HPGDS—lung cancer	1.85e-05	0.000651	CbGpPWpGaD
Nelarabine—DCK—Metabolism—ENO2—lung cancer	1.85e-05	0.000651	CbGpPWpGaD
Nelarabine—Convulsion—Methotrexate—lung cancer	1.85e-05	0.000264	CcSEcCtD
Nelarabine—Vomiting—Etoposide—lung cancer	1.85e-05	0.000264	CcSEcCtD
Nelarabine—Malnutrition—Doxorubicin—lung cancer	1.85e-05	0.000264	CcSEcCtD
Nelarabine—DCK—Metabolism—PPP2R1B—lung cancer	1.84e-05	0.000647	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	1.84e-05	0.000647	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—PTEN—lung cancer	1.84e-05	0.000645	CbGpPWpGaD
Nelarabine—ADA—Metabolism—ENO1—lung cancer	1.83e-05	0.000641	CbGpPWpGaD
Nelarabine—Headache—Etoposide—lung cancer	1.82e-05	0.00026	CcSEcCtD
Nelarabine—Arthralgia—Methotrexate—lung cancer	1.82e-05	0.000259	CcSEcCtD
Nelarabine—Chest pain—Methotrexate—lung cancer	1.82e-05	0.000259	CcSEcCtD
Nelarabine—Myalgia—Methotrexate—lung cancer	1.82e-05	0.000259	CcSEcCtD
Nelarabine—Vomiting—Paclitaxel—lung cancer	1.81e-05	0.000259	CcSEcCtD
Nelarabine—Dysgeusia—Doxorubicin—lung cancer	1.81e-05	0.000258	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	1.8e-05	0.000633	CbGpPWpGaD
Nelarabine—DCK—Metabolism—GSTT1—lung cancer	1.8e-05	0.000631	CbGpPWpGaD
Nelarabine—Back pain—Doxorubicin—lung cancer	1.79e-05	0.000255	CcSEcCtD
Nelarabine—Headache—Paclitaxel—lung cancer	1.79e-05	0.000255	CcSEcCtD
Nelarabine—DCK—Metabolism—CYP2A6—lung cancer	1.78e-05	0.000624	CbGpPWpGaD
Nelarabine—DCK—Metabolism—GCLC—lung cancer	1.78e-05	0.000624	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—BIRC5—lung cancer	1.78e-05	0.000623	CbGpPWpGaD
Nelarabine—Confusional state—Methotrexate—lung cancer	1.76e-05	0.000251	CcSEcCtD
Nelarabine—DGUOK—Metabolism—EP300—lung cancer	1.75e-05	0.000616	CbGpPWpGaD
Nelarabine—Vision blurred—Doxorubicin—lung cancer	1.74e-05	0.000249	CcSEcCtD
Nelarabine—Asthenia—Docetaxel—lung cancer	1.73e-05	0.000248	CcSEcCtD
Nelarabine—Infection—Methotrexate—lung cancer	1.73e-05	0.000247	CcSEcCtD
Nelarabine—Nausea—Etoposide—lung cancer	1.73e-05	0.000247	CcSEcCtD
Nelarabine—POLA1—Cell Cycle—TERT—lung cancer	1.72e-05	0.000604	CbGpPWpGaD
Nelarabine—Nervous system disorder—Methotrexate—lung cancer	1.71e-05	0.000244	CcSEcCtD
Nelarabine—Anaemia—Doxorubicin—lung cancer	1.71e-05	0.000244	CcSEcCtD
Nelarabine—Thrombocytopenia—Methotrexate—lung cancer	1.71e-05	0.000243	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	1.7e-05	0.000598	CbGpPWpGaD
Nelarabine—Nausea—Paclitaxel—lung cancer	1.69e-05	0.000242	CcSEcCtD
Nelarabine—DCK—Metabolism—ENO1—lung cancer	1.68e-05	0.000592	CbGpPWpGaD
Nelarabine—Anorexia—Methotrexate—lung cancer	1.66e-05	0.000237	CcSEcCtD
Nelarabine—Leukopenia—Doxorubicin—lung cancer	1.65e-05	0.000236	CcSEcCtD
Nelarabine—Diarrhoea—Docetaxel—lung cancer	1.65e-05	0.000236	CcSEcCtD
Nelarabine—ADA—Metabolism—CYP2E1—lung cancer	1.64e-05	0.000575	CbGpPWpGaD
Nelarabine—Hypotension—Methotrexate—lung cancer	1.63e-05	0.000232	CcSEcCtD
Nelarabine—Loss of consciousness—Doxorubicin—lung cancer	1.62e-05	0.000232	CcSEcCtD
Nelarabine—ADA—Metabolism—NQO1—lung cancer	1.62e-05	0.000569	CbGpPWpGaD
Nelarabine—Cough—Doxorubicin—lung cancer	1.61e-05	0.00023	CcSEcCtD
Nelarabine—Convulsion—Doxorubicin—lung cancer	1.6e-05	0.000229	CcSEcCtD
Nelarabine—Dizziness—Docetaxel—lung cancer	1.6e-05	0.000228	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Methotrexate—lung cancer	1.59e-05	0.000227	CcSEcCtD
Nelarabine—Insomnia—Methotrexate—lung cancer	1.58e-05	0.000225	CcSEcCtD
Nelarabine—Chest pain—Doxorubicin—lung cancer	1.57e-05	0.000225	CcSEcCtD
Nelarabine—Arthralgia—Doxorubicin—lung cancer	1.57e-05	0.000225	CcSEcCtD
Nelarabine—Myalgia—Doxorubicin—lung cancer	1.57e-05	0.000225	CcSEcCtD
Nelarabine—Paraesthesia—Methotrexate—lung cancer	1.56e-05	0.000223	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	1.56e-05	0.000549	CbGpPWpGaD
Nelarabine—Dyspnoea—Methotrexate—lung cancer	1.55e-05	0.000222	CcSEcCtD
Nelarabine—Somnolence—Methotrexate—lung cancer	1.55e-05	0.000221	CcSEcCtD
Nelarabine—Adenosine triphosphate—ABCB1—lung cancer	1.54e-05	0.00681	CrCbGaD
Nelarabine—Vomiting—Docetaxel—lung cancer	1.54e-05	0.000219	CcSEcCtD
Nelarabine—Confusional state—Doxorubicin—lung cancer	1.52e-05	0.000217	CcSEcCtD
Nelarabine—Decreased appetite—Methotrexate—lung cancer	1.51e-05	0.000216	CcSEcCtD
Nelarabine—Headache—Docetaxel—lung cancer	1.51e-05	0.000216	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	1.51e-05	0.000531	CbGpPWpGaD
Nelarabine—DCK—Metabolism—CYP2E1—lung cancer	1.51e-05	0.000531	CbGpPWpGaD
Nelarabine—Oedema—Doxorubicin—lung cancer	1.51e-05	0.000215	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Methotrexate—lung cancer	1.5e-05	0.000215	CcSEcCtD
Nelarabine—Fatigue—Methotrexate—lung cancer	1.5e-05	0.000214	CcSEcCtD
Nelarabine—Infection—Doxorubicin—lung cancer	1.5e-05	0.000214	CcSEcCtD
Nelarabine—POLA1—Cell Cycle, Mitotic—RB1—lung cancer	1.5e-05	0.000526	CbGpPWpGaD
Nelarabine—DCK—Metabolism—NQO1—lung cancer	1.49e-05	0.000525	CbGpPWpGaD
Nelarabine—Pain—Methotrexate—lung cancer	1.49e-05	0.000213	CcSEcCtD
Nelarabine—Nervous system disorder—Doxorubicin—lung cancer	1.48e-05	0.000211	CcSEcCtD
Nelarabine—Thrombocytopenia—Doxorubicin—lung cancer	1.48e-05	0.000211	CcSEcCtD
Nelarabine—ADA—Metabolism—STK11—lung cancer	1.46e-05	0.000513	CbGpPWpGaD
Nelarabine—Anorexia—Doxorubicin—lung cancer	1.44e-05	0.000205	CcSEcCtD
Nelarabine—Nausea—Docetaxel—lung cancer	1.44e-05	0.000205	CcSEcCtD
Nelarabine—Feeling abnormal—Methotrexate—lung cancer	1.44e-05	0.000205	CcSEcCtD
Nelarabine—Gastrointestinal pain—Methotrexate—lung cancer	1.42e-05	0.000203	CcSEcCtD
Nelarabine—Hypotension—Doxorubicin—lung cancer	1.41e-05	0.000201	CcSEcCtD
Nelarabine—Abdominal pain—Methotrexate—lung cancer	1.38e-05	0.000197	CcSEcCtD
Nelarabine—Body temperature increased—Methotrexate—lung cancer	1.38e-05	0.000197	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Doxorubicin—lung cancer	1.37e-05	0.000196	CcSEcCtD
Nelarabine—Insomnia—Doxorubicin—lung cancer	1.36e-05	0.000195	CcSEcCtD
Nelarabine—Paraesthesia—Doxorubicin—lung cancer	1.35e-05	0.000193	CcSEcCtD
Nelarabine—ADA—Metabolism—GSTP1—lung cancer	1.35e-05	0.000474	CbGpPWpGaD
Nelarabine—DCK—Metabolism—STK11—lung cancer	1.35e-05	0.000473	CbGpPWpGaD
Nelarabine—Dyspnoea—Doxorubicin—lung cancer	1.35e-05	0.000192	CcSEcCtD
Nelarabine—Somnolence—Doxorubicin—lung cancer	1.34e-05	0.000191	CcSEcCtD
Nelarabine—POLA1—Cell Cycle—RB1—lung cancer	1.34e-05	0.00047	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—CDKN2A—lung cancer	1.32e-05	0.000462	CbGpPWpGaD
Nelarabine—ADA—Metabolism—CAT—lung cancer	1.31e-05	0.000461	CbGpPWpGaD
Nelarabine—Decreased appetite—Doxorubicin—lung cancer	1.31e-05	0.000187	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Doxorubicin—lung cancer	1.3e-05	0.000186	CcSEcCtD
Nelarabine—Fatigue—Doxorubicin—lung cancer	1.3e-05	0.000186	CcSEcCtD
Nelarabine—DGUOK—Metabolism—PIK3CA—lung cancer	1.3e-05	0.000455	CbGpPWpGaD
Nelarabine—Constipation—Doxorubicin—lung cancer	1.29e-05	0.000184	CcSEcCtD
Nelarabine—Pain—Doxorubicin—lung cancer	1.29e-05	0.000184	CcSEcCtD
Nelarabine—ADA—Metabolism—ABCB1—lung cancer	1.28e-05	0.000449	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	1.28e-05	0.000449	CbGpPWpGaD
Nelarabine—ADA—Metabolism—TYMS—lung cancer	1.26e-05	0.000441	CbGpPWpGaD
Nelarabine—Asthenia—Methotrexate—lung cancer	1.25e-05	0.000178	CcSEcCtD
Nelarabine—DCK—Metabolism—GSTP1—lung cancer	1.25e-05	0.000438	CbGpPWpGaD
Nelarabine—Feeling abnormal—Doxorubicin—lung cancer	1.24e-05	0.000177	CcSEcCtD
Nelarabine—ADA—Metabolism—GSTM1—lung cancer	1.24e-05	0.000436	CbGpPWpGaD
Nelarabine—Gastrointestinal pain—Doxorubicin—lung cancer	1.23e-05	0.000176	CcSEcCtD
Nelarabine—POLA1—Mitotic M-M/G1 phases—MAPK3—lung cancer	1.23e-05	0.00043	CbGpPWpGaD
Nelarabine—DCK—Metabolism—CAT—lung cancer	1.21e-05	0.000426	CbGpPWpGaD
Nelarabine—Body temperature increased—Doxorubicin—lung cancer	1.19e-05	0.00017	CcSEcCtD
Nelarabine—Abdominal pain—Doxorubicin—lung cancer	1.19e-05	0.00017	CcSEcCtD
Nelarabine—Diarrhoea—Methotrexate—lung cancer	1.19e-05	0.00017	CcSEcCtD
Nelarabine—DCK—Metabolism—ABCB1—lung cancer	1.18e-05	0.000414	CbGpPWpGaD
Nelarabine—ADA—Metabolism—CYP1A1—lung cancer	1.18e-05	0.000413	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—CDKN2A—lung cancer	1.18e-05	0.000413	CbGpPWpGaD
Nelarabine—ADA—Metabolism—ERCC2—lung cancer	1.17e-05	0.00041	CbGpPWpGaD
Nelarabine—DCK—Metabolism—TYMS—lung cancer	1.16e-05	0.000407	CbGpPWpGaD
Nelarabine—Dizziness—Methotrexate—lung cancer	1.15e-05	0.000164	CcSEcCtD
Nelarabine—DCK—Metabolism—GSTM1—lung cancer	1.15e-05	0.000402	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—MDM2—lung cancer	1.14e-05	0.000401	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—CCND1—lung cancer	1.11e-05	0.00039	CbGpPWpGaD
Nelarabine—Vomiting—Methotrexate—lung cancer	1.11e-05	0.000158	CcSEcCtD
Nelarabine—Headache—Methotrexate—lung cancer	1.09e-05	0.000156	CcSEcCtD
Nelarabine—DCK—Metabolism—CYP1A1—lung cancer	1.09e-05	0.000381	CbGpPWpGaD
Nelarabine—Asthenia—Doxorubicin—lung cancer	1.08e-05	0.000154	CcSEcCtD
Nelarabine—DCK—Metabolism—ERCC2—lung cancer	1.08e-05	0.000378	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—CDKN1A—lung cancer	1.08e-05	0.000378	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—AKT1—lung cancer	1.06e-05	0.000372	CbGpPWpGaD
Nelarabine—Nausea—Methotrexate—lung cancer	1.03e-05	0.000148	CcSEcCtD
Nelarabine—Diarrhoea—Doxorubicin—lung cancer	1.03e-05	0.000147	CcSEcCtD
Nelarabine—POLA1—Cell Cycle, Mitotic—EP300—lung cancer	1.02e-05	0.000359	CbGpPWpGaD
Nelarabine—ADA—Metabolism—APOA1—lung cancer	1.01e-05	0.000354	CbGpPWpGaD
Nelarabine—Dizziness—Doxorubicin—lung cancer	9.98e-06	0.000142	CcSEcCtD
Nelarabine—POLA1—Cell Cycle—CCND1—lung cancer	9.94e-06	0.000349	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—CDKN1A—lung cancer	9.61e-06	0.000338	CbGpPWpGaD
Nelarabine—Vomiting—Doxorubicin—lung cancer	9.59e-06	0.000137	CcSEcCtD
Nelarabine—Headache—Doxorubicin—lung cancer	9.45e-06	0.000135	CcSEcCtD
Nelarabine—DCK—Metabolism—APOA1—lung cancer	9.32e-06	0.000327	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PIK3CG—lung cancer	9.21e-06	0.000324	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—MAPK3—lung cancer	9.17e-06	0.000322	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—EP300—lung cancer	9.15e-06	0.000321	CbGpPWpGaD
Nelarabine—Nausea—Doxorubicin—lung cancer	8.96e-06	0.000128	CcSEcCtD
Nelarabine—POLA1—Cell Cycle, Mitotic—MYC—lung cancer	8.92e-06	0.000313	CbGpPWpGaD
Nelarabine—ADA—Metabolism—POMC—lung cancer	8.77e-06	0.000308	CbGpPWpGaD
Nelarabine—ADA—Metabolism—CREBBP—lung cancer	8.54e-06	0.0003	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PIK3CG—lung cancer	8.5e-06	0.000299	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—MAPK3—lung cancer	8.2e-06	0.000288	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PIK3CD—lung cancer	8.1e-06	0.000284	CbGpPWpGaD
Nelarabine—DCK—Metabolism—POMC—lung cancer	8.09e-06	0.000284	CbGpPWpGaD
Nelarabine—ADA—Metabolism—ALB—lung cancer	8e-06	0.000281	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—MYC—lung cancer	7.97e-06	0.00028	CbGpPWpGaD
Nelarabine—DCK—Metabolism—CREBBP—lung cancer	7.88e-06	0.000277	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PIK3CD—lung cancer	7.48e-06	0.000263	CbGpPWpGaD
Nelarabine—DCK—Metabolism—ALB—lung cancer	7.38e-06	0.000259	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PIK3CB—lung cancer	7.06e-06	0.000248	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PTGS2—lung cancer	7e-06	0.000246	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—TP53—lung cancer	6.55e-06	0.00023	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PIK3CB—lung cancer	6.52e-06	0.000229	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PTGS2—lung cancer	6.46e-06	0.000227	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PTEN—lung cancer	6.1e-06	0.000214	CbGpPWpGaD
Nelarabine—ADA—Metabolism—EP300—lung cancer	5.82e-06	0.000204	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PTEN—lung cancer	5.63e-06	0.000198	CbGpPWpGaD
Nelarabine—DCK—Metabolism—EP300—lung cancer	5.37e-06	0.000189	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PIK3CA—lung cancer	4.3e-06	0.000151	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PIK3CA—lung cancer	3.97e-06	0.00014	CbGpPWpGaD
Nelarabine—ADA—Metabolism—AKT1—lung cancer	3.52e-06	0.000123	CbGpPWpGaD
Nelarabine—DCK—Metabolism—AKT1—lung cancer	3.25e-06	0.000114	CbGpPWpGaD
